Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH March 28, 2022
IBD-3540, a novel gut-restricted GCPII inhibitor with oral preclinical activity in models of colitis Feb. 21, 2022
DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity Feb. 1, 2022
New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding Jan. 31, 2022
Dual Kv7 channel/TPSO receptor activator GRT-X shows promise in a refractory seizure model Jan. 31, 2022
RSS